Skip to main content
Aldosterone Antagonism With Eplerenone Does Not Adversely Affect Plasma Glucose Levels in Patients With Diabetes Mellitus: Findings From a Post Hoc Analysis of the EPHESUS Trial
Department of Medicine
  • Prakash Deedwania, MD, University of California - San Francisco
  • Bertram Pitt, University of Michigan
  • Ravi V Desai, MD, Lehigh Valley Health Network
  • Marjan Mujib, MD, MPH, University of Alabama - Birmingham
  • Inmaculada B Aban, PhD, University of Alabama - Birmingham
  • J Vincent, Pfizer - New York
  • E Turgonyi, Pfizer - New York
  • Ali Ahmed, MD, MPH, University of Alabama - Birmingham
Publication/Presentation Date

European Heart Journal ( 2010 ) 31 ( Abstract Supplement ), 423-424

Document Type
Citation Information

Deedwania, P., Pitt, B., Desai, R., Mujib, M., Aban, I., Vincent, J., Turgonyi, E., & Ahmed, A. (2010, August 28-September 1). Aldosterone antagonism with eplerenone does not adversely affect plasma glucose levels in patients with diabetes mellitus: Findings from a post hoc analysis of the EPHESUS trial. Poster presented at: The 2010 European Society of Cardiology Congress, Stockholm, Sweden.